Szczegółowy przewodnik wkrótce
Pracujemy nad kompleksowym przewodnikiem edukacyjnym dla Rockall Score (Upper GI Bleed). Wróć wkrótce po wyjaśnienia krok po kroku, wzory, przykłady z życia i porady ekspertów.
The Rockall Score is a widely used clinical scoring system for risk stratification of patients presenting with acute upper gastrointestinal bleeding (UGIB). Developed by Tim Rockall and colleagues in 1996 using data from over 4,800 patients in a national UK audit, it was the first validated prognostic tool for UGIB. The score exists in two forms: the pre-endoscopy Rockall score (using age, shock status, and comorbidities), and the complete post-endoscopy Rockall score, which adds endoscopic diagnosis and stigmata of recent haemorrhage. The complete score ranges from 0 to 11 points. Unlike the Glasgow-Blatchford Score, which excels at identifying low-risk patients safe for discharge, the Rockall score is better suited to predicting rebleeding risk and 30-day mortality once endoscopy has confirmed the diagnosis. A complete Rockall score of 0–2 is associated with very low rebleeding risk (approximately 5%) and low mortality, supporting early discharge after successful endoscopy. Scores of 3–4 indicate intermediate risk, while scores of 5 or above carry clinically significant rebleeding risk requiring intensive monitoring. Scores of 8 or higher are associated with rebleeding rates exceeding 40% and 30-day mortality above 40%, warranting ICU-level care. The Rockall score is particularly valuable for post-endoscopy care planning, discharge timing, and counselling patients about expected clinical course.
Pre-endoscopy Rockall = points(age) + points(shock) + points(comorbidity); Complete Rockall adds + points(endoscopic diagnosis) + points(stigmata of recent haemorrhage); Total range 0–11
- 1Assess patient age and assign points: 0 pts for age <60 years, 1 pt for age 60–79 years, 2 pts for age ≥80 years.
- 2Assess haemodynamic shock: 0 pts for no shock (HR <100, SBP ≥100 mmHg), 1 pt for tachycardia only (HR ≥100, SBP ≥100), 2 pts for hypotension (SBP <100 mmHg regardless of HR).
- 3Assess comorbidities: 0 pts for none; 2 pts for cardiac failure, ischaemic heart disease, or any major comorbidity; 3 pts for renal failure, hepatic failure, or disseminated malignancy.
- 4After endoscopy, add the diagnosis component: 0 pts for Mallory-Weiss tear or no lesion; 1 pt for all other diagnoses (peptic ulcer, erosive disease); 2 pts for malignancy of the upper GI tract.
- 5After endoscopy, add stigmata of recent haemorrhage: 0 pts for clean base ulcer or flat pigmented spot; 1 pt for blood in upper GI tract, adherent clot, visible vessel, or active bleeding.
- 6Sum all applicable components to obtain the pre-endoscopy Rockall (max 7) or complete Rockall score (max 11).
- 7Interpret: score 0–2 = low risk (~5% rebleeding); 3–4 = intermediate risk; 5–7 = high risk; ≥8 = very high risk (>40% rebleed and >40% mortality).
Low risk — same-day discharge after endoscopy is appropriate
Young patient with no comorbidities and a clean-based ulcer at endoscopy. Rebleeding risk is minimal and inpatient monitoring beyond recovery from endoscopy is not required.
High risk — requires at least 72 hours inpatient monitoring and repeat endoscopy consideration
Multiple intermediate-risk features compound to produce a high-risk score. Rebleeding risk is around 15–20% and close monitoring is mandatory.
Very high risk — ICU admission and palliative/surgical discussion required
Maximum scores across almost all domains indicate an extremely high rebleeding and mortality risk. This patient requires intensive care and urgent multidisciplinary discussion about prognosis and goals of care.
Intermediate-to-high pre-endoscopy risk — urgent endoscopy within 12 hours
Even without endoscopy results, this patient's age, hepatic cirrhosis comorbidity places them in a high-risk category requiring urgent endoscopy and likely ICU-level monitoring.
Post-endoscopy care planning: the complete Rockall score guides decisions on length of hospital stay, ICU vs. ward monitoring, and need for repeat endoscopy at 24 hours., representing an important application area for the Rockall Score in professional and analytical contexts where accurate rockall score calculations directly support informed decision-making, strategic planning, and performance optimization
Discharge timing: gastroenterologists use low complete Rockall scores (0–2) alongside successful haemostasis to safely discharge patients and free hospital beds., representing an important application area for the Rockall Score in professional and analytical contexts where accurate rockall score calculations directly support informed decision-making, strategic planning, and performance optimization
Rebleeding risk counselling: clinicians use the Rockall score to counsel patients and families about the likelihood of rebleeding, informing shared decision-making about endoscopic re-treatment vs. surgery., representing an important application area for the Rockall Score in professional and analytical contexts where accurate rockall score calculations directly support informed decision-making, strategic planning, and performance optimization
Audit and quality improvement: hospitals use aggregate Rockall score distributions to benchmark their UGIB outcomes against national standards and identify areas for care improvement., representing an important application area for the Rockall Score in professional and analytical contexts where accurate rockall score calculations directly support informed decision-making, strategic planning, and performance optimization
Blood product pre-ordering: high pre-endoscopy Rockall scores prompt early activation of blood bank alerts and crossmatch for potential massive transfusion., representing an important application area for the Rockall Score in professional and analytical contexts where accurate rockall score calculations directly support informed decision-making, strategic planning, and performance optimization
Mallory-Weiss tears
In the Rockall Score, this scenario requires additional caution when interpreting rockall score results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when rockall score calculations fall into non-standard territory.
Disseminated malignancy as comorbidity
In the Rockall Score, this scenario requires additional caution when interpreting rockall score results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when rockall score calculations fall into non-standard territory.
Endoscopic haemostasis and score interpretation
{'title': 'Endoscopic haemostasis and score interpretation', 'body': 'The Rockall score does not account for successful endoscopic haemostasis. A patient with a visible vessel (1 stigmata point) who has undergone successful adrenaline injection plus clipping may have a lower actual rebleeding risk than the score alone suggests. Clinical judgement must supplement the score.'}
Concurrent anticoagulation
In the Rockall Score, this scenario requires additional caution when interpreting rockall score results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when rockall score calculations fall into non-standard territory.
| Component | 0 Points | 1 Point | 2 Points | 3 Points |
|---|---|---|---|---|
| Age | < 60 | 60–79 | ≥ 80 | — |
| Shock | No shock (HR<100, SBP≥100) | Tachycardia (HR≥100, SBP≥100) | Hypotension (SBP<100) | — |
| Comorbidity | None | — | CCF, IHD, major comorbidity | Renal/liver failure, disseminated malignancy |
| Endoscopic Diagnosis | Mallory-Weiss or no lesion | All other diagnoses | GI malignancy | — |
| Stigmata of Haemorrhage | Clean base or flat spot | Blood, clot, visible vessel, active bleed | — | — |
| Complete Score 0–2 | ~5% rebleed | Low 30-day mortality | Early discharge candidate | — |
| Complete Score ≥ 8 | >40% rebleed | High 30-day mortality | ICU-level care required | — |
What is the Rockall score used for?
The Rockall score predicts rebleeding risk and 30-day mortality in patients with acute upper gastrointestinal bleeding. The complete post-endoscopy version is particularly useful for planning post-endoscopy care, deciding on discharge timing, and identifying patients needing ICU admission or repeat intervention. This is particularly important in the context of rockall score calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rockall score computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
What is the difference between the pre-endoscopy and complete Rockall score?
The pre-endoscopy Rockall uses only age, shock status, and comorbidity (maximum 7 points) and can be calculated immediately on presentation. The complete Rockall adds endoscopic diagnosis and stigmata of recent haemorrhage (maximum 11 points) once endoscopy is performed, providing more precise risk stratification. This is particularly important in the context of rockall score calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rockall score computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
What Rockall score allows safe discharge?
A complete Rockall score of 0–2 combined with successful endoscopic haemostasis (or absence of high-risk stigmata) is generally considered safe for early discharge. Some centres discharge Rockall 0 patients on the same day as endoscopy if they are haemodynamically stable and have reliable follow-up. This is particularly important in the context of rockall score calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rockall score computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
How does Rockall compare to Glasgow-Blatchford Score?
The Glasgow-Blatchford Score is superior for pre-endoscopic risk stratification, particularly for identifying low-risk patients safe for outpatient management (GBS 0). The Rockall score provides better post-endoscopic rebleeding and mortality prediction. Many guidelines recommend using GBS for initial triage and complete Rockall after endoscopy. This is particularly important in the context of rockall score calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rockall score computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
Does malignancy always score the highest diagnosis points?
Yes. Upper GI tract malignancy scores 2 points for the diagnosis component — the highest available — reflecting the very poor haemostatic outcomes and high rebleeding rates associated with tumour bleeding, which often cannot be definitively controlled endoscopically. This is particularly important in the context of rockall score calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rockall score computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
What counts as a major comorbidity in the Rockall score?
The Rockall comorbidity component distinguishes three levels: none (0 points), any major comorbidity including cardiac failure, ischaemic heart disease, or any major comorbidity (2 points), and renal failure, hepatic failure, or disseminated malignancy (3 points) — the highest-risk group. This is particularly important in the context of rockall score calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rockall score computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
Is the Rockall score validated outside the UK?
Yes. The Rockall score has been externally validated in multiple large cohorts across Europe, North America, and Asia, consistently demonstrating its discriminative ability for rebleeding and mortality prediction in UGIB populations. This is particularly important in the context of rockall score calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rockall score computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
Can the Rockall score be used for variceal bleeding?
The Rockall score was derived from a mixed UGIB population that included some variceal cases, but it is less well validated specifically for oesophageal variceal bleeding. Variceal-specific tools (such as HVPG measurement, Child-Pugh, and MELD) are preferred for prognosis in variceal haemorrhage. This is particularly important in the context of rockall score calculations, where accuracy directly impacts decision-making. Professionals across multiple industries rely on precise rockall score computations to validate assumptions, optimize processes, and ensure compliance with applicable standards. Understanding the underlying methodology helps users interpret results correctly and identify when additional analysis may be warranted.
Wskazówka Pro
For the most complete and clinically actionable risk assessment in UGIB, use the Glasgow-Blatchford Score at initial presentation for admission decisions, and complete the Rockall score after endoscopy to guide discharge timing and post-procedure monitoring intensity.
Czy wiedziałeś?
The original Rockall score was developed from a prospective national UK audit of 4,185 cases of acute upper GI haemorrhage collected across 74 hospitals in 1993 — one of the largest GI bleeding datasets of its era. The validation was performed on a separate cohort of 1,625 patients, making it one of the most rigorously derived scoring tools in gastroenterology.
Źródła
- ›Rockall TA et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996.
- ›Vreeburg EM et al. Validation of the Rockall risk score for upper gastrointestinal bleeding. Gut 1999.
- ›BSG Guidelines on Management of Acute Upper GI Bleeding 2002 (updated by NICE CG141)
- ›MDCalc — Rockall Score for Upper GI Bleeding
- ›Stanley AJ et al. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding. BMJ 2017.